NO994412L - Doseringsformer omfattende separate deler av R- og S-enantiomerer - Google Patents

Doseringsformer omfattende separate deler av R- og S-enantiomerer

Info

Publication number
NO994412L
NO994412L NO994412A NO994412A NO994412L NO 994412 L NO994412 L NO 994412L NO 994412 A NO994412 A NO 994412A NO 994412 A NO994412 A NO 994412A NO 994412 L NO994412 L NO 994412L
Authority
NO
Norway
Prior art keywords
enantiomers
dosage form
dosage forms
separate portions
enantiomer
Prior art date
Application number
NO994412A
Other languages
English (en)
Norwegian (no)
Other versions
NO994412D0 (no
Inventor
Julian Clive Gilbert
Andrew John Mcglashan Richards
Hazel Judith Bardsley
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9704978.7A external-priority patent/GB9704978D0/en
Priority claimed from GBGB9719261.1A external-priority patent/GB9719261D0/en
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Publication of NO994412D0 publication Critical patent/NO994412D0/no
Publication of NO994412L publication Critical patent/NO994412L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
NO994412A 1997-03-11 1999-09-10 Doseringsformer omfattende separate deler av R- og S-enantiomerer NO994412L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9704978.7A GB9704978D0 (en) 1997-03-11 1997-03-11 Dosage forms
GBGB9719261.1A GB9719261D0 (en) 1997-09-10 1997-09-10 Dosage forms
PCT/GB1998/000726 WO1998040053A1 (fr) 1997-03-11 1998-03-11 Formes galeniques comprenant des parties separees d'enantiomeres r et s
US09/038,873 US6056968A (en) 1997-03-11 1998-03-11 Pharmaceutical drug dosage forms providing different release rates

Publications (2)

Publication Number Publication Date
NO994412D0 NO994412D0 (no) 1999-09-10
NO994412L true NO994412L (no) 1999-10-20

Family

ID=27268767

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994412A NO994412L (no) 1997-03-11 1999-09-10 Doseringsformer omfattende separate deler av R- og S-enantiomerer

Country Status (15)

Country Link
US (2) US6056968A (fr)
EP (1) EP0969818B1 (fr)
JP (1) JP2001514651A (fr)
CN (1) CN1251987A (fr)
AT (1) ATE275394T1 (fr)
AU (1) AU741821B2 (fr)
BR (1) BR9808325A (fr)
CA (1) CA2285407C (fr)
DE (1) DE69826113T2 (fr)
ES (1) ES2227814T3 (fr)
HU (1) HUP0000759A3 (fr)
IL (1) IL131713A (fr)
NO (1) NO994412L (fr)
PL (1) PL335619A1 (fr)
WO (1) WO1998040053A1 (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262115B1 (en) * 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
US5912268A (en) * 1995-05-22 1999-06-15 Alza Corporation Dosage form and method for treating incontinence
BR9915873A (pt) * 1998-12-02 2001-08-21 Darwin Discovery Ltd Produto terapêutico e seu uso
AU3064800A (en) * 1999-01-21 2000-08-07 Darwin Discovery Limited The therapeutic use of r-warfarin as anticoagulant
US20030170181A1 (en) * 1999-04-06 2003-09-11 Midha Kamal K. Method for preventing abuse of methylphenidate
PE20010623A1 (es) * 1999-10-05 2001-07-07 Gruenenthal Chemie Uso de (+)-tramadol y/o o-demetiltramadol para tratamiento de urgencia urinaria incrementada y/o incontinencia urinaria
WO2001034125A2 (fr) * 1999-11-09 2001-05-17 Darwin Discovery Limited Utilisation et formulation therapeutiques
DE10004926A1 (de) 2000-02-04 2001-08-09 Gruenenthal Gmbh Verfahren zur enzymatischen Racematspaltung von Aminomethyl-Aryl-Cyclohexanol-Derivaten
JP5042425B2 (ja) 2000-03-01 2012-10-03 ユーロセルティック ソシエテ アノニム 機能性胃腸疾患治療用トラマドール
US20010036959A1 (en) * 2000-04-03 2001-11-01 Gabel Rolf Dieter Carvedilol-hydrophilic solutions
KR20030059803A (ko) * 2000-10-03 2003-07-10 펜웨스트 파마슈티칼스 컴퍼니 다수의 약학적 활성 물질을 다양한 방출 속도로 전달하는시스템
AU2001297631A1 (en) * 2000-10-24 2002-09-04 Smithkline Beecham Corporation Novel formulations of carvedilol
US6562871B1 (en) * 2000-11-06 2003-05-13 Boehringer Ingelheim Pharmaceuticals, Inc. Dry granulation of pharmaceutical formulation comprising mexiletine
DE10108122A1 (de) 2001-02-21 2002-10-02 Gruenenthal Gmbh Arzneimittel auf Basis von Tramadol
IN191028B (fr) * 2001-05-17 2003-09-13 Sun Pharmaceutical Ind Ltd
US8101209B2 (en) * 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
AU2002364517A1 (en) 2001-11-30 2003-06-17 Sepracor Inc. Tramadol analogs and uses thereof
US8128957B1 (en) 2002-02-21 2012-03-06 Valeant International (Barbados) Srl Modified release compositions of at least one form of tramadol
US20050182056A9 (en) * 2002-02-21 2005-08-18 Seth Pawan Modified release formulations of at least one form of tramadol
AU2003275953A1 (en) * 2002-11-08 2004-06-07 Egalet A/S Controlled release carvedilol compositions
AU2003288608A1 (en) * 2002-12-20 2004-07-14 Ranbaxy Laboratories Limited Controlled release, multiple unit drug delivery systems
WO2004071501A1 (fr) * 2003-02-10 2004-08-26 Shire Biochem Inc. Compositions enantiomeriques d'amphetamine pour traiter l'adhd
WO2004103361A2 (fr) * 2003-05-20 2004-12-02 Ranbaxy Laboratories Limited Forme posologique pharmaceutique de citalopram
BRPI0411039A (pt) * 2003-06-06 2006-07-11 Ethypharm Sa comprimido orodispersìvel multicamada
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
US20050143350A1 (en) * 2003-11-19 2005-06-30 Seed John C. Combination drug therapy to treat obesity
EP1691789B1 (fr) 2003-11-25 2017-12-20 SmithKline Beecham (Cork) Limited Base libre de carvedilol, ses sels, formes anhydres ou solvates, compositions pharmaceutiques correspondantes, formulations a liberation controlee, et procedes de traitement ou d'administration
EP1686967A4 (fr) * 2003-11-25 2012-08-08 Smithkline Beecham Cork Ltd Base libre de carvedilol, ses sels, formes anhydres ou solvats, compositions pharmaceutiques correspondantes, formulations a liberation controlee, et methodes de traitement ou d'administration
EP1802258A4 (fr) 2004-09-13 2015-09-23 Chrono Therapeutics Inc Administration de medicament transdermique biosynchrone
KR20070058540A (ko) * 2004-10-01 2007-06-08 니폰 조키 세야쿠 가부시키가이샤 고형 의약제제
BRPI0615860B8 (pt) 2005-09-09 2021-05-25 Labopharm Barbados Ltd composição farmacêutica de liberação prolongada monolítica sólida
WO2007080509A2 (fr) * 2006-01-12 2007-07-19 Wockhardt Ltd Préparations à libération prolongée d'alfuzosine
ES2744495T3 (es) * 2006-03-30 2020-02-25 Nippon Zoki Pharmaceutical Co Preparación farmacéutica sólida
SG178775A1 (en) 2007-02-12 2012-03-29 Dmi Biosciences Inc Reducing side effects of tramadol
MX2009008491A (es) * 2007-02-12 2010-01-20 Dmi Biosciences Inc Tratamiento de disfuncion erectil y eyaculacion prematura copatologicas.
GB2448224B (en) 2007-04-02 2010-09-01 Parkinson S Inst Solid orally administered pharmaceutical composition for the reduction of side-effects of a dopaminergic agent
US10213586B2 (en) 2015-01-28 2019-02-26 Chrono Therapeutics Inc. Drug delivery methods and systems
WO2018129304A1 (fr) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Dispositifs et methodes d'administration transdermique de medicament
AU2019279884A1 (en) 2018-05-29 2020-12-10 Morningside Venture Investments Limited Drug delivery methods and systems

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4818541A (en) * 1987-08-19 1989-04-04 Schering Corporation Transdermal delivery of enantiomers of phenylpropanolamine
US5145866A (en) * 1991-04-22 1992-09-08 Hoechst-Roussel Pharmaceuticals Incorporated Method of treating anxiety with the aid of r(+)-3-amino-1-hydroxy-pyrrolidin-2-one
US5204116A (en) * 1991-05-01 1993-04-20 Alza Corporation Dosage form providing immediate therapy followed by prolonged therapy
IL109460A (en) * 1993-05-10 1998-03-10 Euro Celtique Sa Controlled release formulation comprising tramadol
DE4319438C1 (de) * 1993-06-11 1994-06-01 Gerd Dr Dr Geislinger Arzneimittel auf der Grundlage von Ketoprofen zur Bekämpfung von Schmerzen und/oder Entzündungen und/oder Fieber an Menschen und Tieren
GB9412689D0 (en) * 1994-06-23 1994-08-10 Chiroscience Ltd Cytotoxic agent and its use

Also Published As

Publication number Publication date
US6221394B1 (en) 2001-04-24
US6056968A (en) 2000-05-02
CA2285407A1 (fr) 1998-09-17
CA2285407C (fr) 2006-08-01
HUP0000759A2 (hu) 2000-10-28
PL335619A1 (en) 2000-05-08
AU741821B2 (en) 2001-12-13
AU6508998A (en) 1998-09-29
NO994412D0 (no) 1999-09-10
WO1998040053A1 (fr) 1998-09-17
IL131713A (en) 2004-08-31
IL131713A0 (en) 2001-03-19
HUP0000759A3 (en) 2000-11-28
DE69826113T2 (de) 2005-01-20
DE69826113D1 (de) 2004-10-14
EP0969818B1 (fr) 2004-09-08
ATE275394T1 (de) 2004-09-15
EP0969818A1 (fr) 2000-01-12
CN1251987A (zh) 2000-05-03
ES2227814T3 (es) 2005-04-01
JP2001514651A (ja) 2001-09-11
BR9808325A (pt) 2000-05-16

Similar Documents

Publication Publication Date Title
NO994412L (no) Doseringsformer omfattende separate deler av R- og S-enantiomerer
DE50008336D1 (de) Mehrschichttablette zur verabreichung einer fixen kombination von tramadol und diclofenac
WO2008151803A3 (fr) Nouveaux polymorphismes du gène abcb1 associés à une absence de réaction clinique à des médicaments
WO2005070462A3 (fr) Compositions comprenant de la (s)-amlodipine et un bloqueur du recepteur de l'angiotensine, et leurs methodes d'utilisation
JP2003503454A5 (fr)
DK1162982T3 (da) Anvendelse af stabiliserede oligonucleotider til fremstilling af et lægemiddel med antitumoral virkning
JP2007522094A5 (fr)
NO324227B1 (no) Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer
PL367264A1 (en) Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
JP2007514005A5 (fr)
DE60034240D1 (de) Drogen zur behandlung maligner tumoren
HUP0302476A2 (hu) Acetilkolinészteráz inhibitorok és GABAA inverz agonisták együttes alkalmazása értelmi rendellenességek kezelésére és gyógyszerkészítmények előállítására
WO2002065979A3 (fr) Nouveaux composes de pyrimidine
EP1445253A4 (fr) Derives de 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine, ou sels desdits derives
WO2003087049A3 (fr) Combinaisons de produits pharmaceutiques contenant des composes heterocycliques et un nouvel anticholinergique
AU2003293593A8 (en) Pharmaceutical preparations, use of said preparations and method for increasing the bioavailability of medicaments for peroral administration
WO2002092072A3 (fr) Medicaments contre la maladie d'alzheimer
DK1643999T3 (da) Pyridoxamin til anvendelse ved behandlingen af diabetisk nefropati ved type 2-diabetes
WO2005118845A3 (fr) Utilisation d'une modification genetique dans le gene humain gnaq pour prevoir des risques de maladie, le deroulement d'une maladie et la reaction a des therapies
WO2000010554A3 (fr) Procedes et compositions employant le vigabatrin s(+) optiquement pur
WO2001079560A3 (fr) Test de reaction a des medicaments contre des maladies respiratoires
WO2003002059A3 (fr) Metabolites de tolterodine
HUP0402298A2 (hu) Dezoxipeganin alkalmazása klinikai depresszió kezelésére
WO2005016898A3 (fr) Forme cristalline stable de bifeprunox mesylate (7-[4-([1,1'-biphenyl]-3-ylmetheyl)-1-piperazinyl]-2(3h)-benzoxazolone monomethanesulfonate
Yam et al. Hyperglycemia and late onset seizures associated with quetiapine overdose

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application